Advertisement

The Scientist

» clinical trials

Most Recent

image: A Placebo for Schizophrenia?

A Placebo for Schizophrenia?

By | June 26, 2012

The placebo effect in clinical trials of the mental disorder has increased over the past decade.

1 Comment

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: Opinion: On the Up and Up

Opinion: On the Up and Up

By | June 20, 2012

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.

5 Comments

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

image: FDA OKs Early Stage Trials

FDA OKs Early Stage Trials

By | June 5, 2012

The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.

1 Comment

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Trials Overlook Cancer Spread

Trials Overlook Cancer Spread

By | May 30, 2012

One cancer researcher says that by focusing solely on stalling cancer growth, clinical trials are failing some potentially life-saving drugs that prevent metastasis.

0 Comments

image: Overhauling Industry-Sponsored Studies

Overhauling Industry-Sponsored Studies

By | May 23, 2012

Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.

1 Comment

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies